Temsirolimus, interferon alfa or both in advanced renal-cell carcinoma: One plus one does not always equal two.
Grover
S
S
Department of Urology, Christian Medical College, Vellore, India. E-mail: chandrasingh@cmcvellore.ac.in.
Singh
J C
JC
Kekre
N S
NS